Regenexx Publishes ACL Healing Study

Regenexx published its randomized controlled trial (RCT) mid-term results showing primary anterior cruciate ligament (ACL) healing without the need for invasive surgery. This was achieved through precise, image-guided injections of autologous bone marrow concentrate and platelets in patients failing conservative care. The goal of the study was to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us